Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Maastricht University Medical Center
Incyte Corporation
Intensity Therapeutics, Inc.
The Netherlands Cancer Institute
Incyte Corporation
Incyte Corporation